These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37651160)

  • 1. Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
    Brown JC; Ma C; Shi Q; Zemla T; Couture F; Kuebler P; Kumar P; Tan B; Krishnamurthi S; Chang V; Goldberg RM; Venook AP; Blanke CD; O'Reilly EM; Shields AF; Meyerhardt JA
    Cancer; 2023 Dec; 129(23):3724-3734. PubMed ID: 37651160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
    Brown JC; Ma C; Shi Q; Fuchs CS; Meyer J; Niedzwiecki D; Zemla T; Couture F; Kuebler P; Kumar P; Lewis D; Tan B; Krishnamurthi S; O'Reilly EM; Shields AF; Meyerhardt JA
    J Clin Oncol; 2023 Jan; 41(2):243-254. PubMed ID: 35944235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
    Meyerhardt JA; Heseltine D; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Thomas J; Nelson H; Whittom R; Hantel A; Schilsky RL; Fuchs CS
    J Clin Oncol; 2006 Aug; 24(22):3535-41. PubMed ID: 16822843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between physical activity and the time course of cancer recurrence in stage III colon cancer.
    Brown JC; Ma C; Shi Q; Niedzwiecki D; Zemla T; Couture F; Kuebler P; Kumar P; Hopkins JO; Tan B; Krishnamurthi S; O'Reilly EM; Shields AF; Meyerhardt JA
    Br J Sports Med; 2023 Aug; 57(15):965-971. PubMed ID: 36878665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
    Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; O'Neil BH; Shaw JE; Polite BN; Hochster HS; Atkins JN; Goldberg RM; Sato K; Ng K; Van Blarigan E; Mayer RJ; Blanke CD; O'Reilly EM; Fuchs CS; Meyerhardt JA
    J Clin Oncol; 2019 Oct; 37(29):2620-2631. PubMed ID: 31408415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
    Meyerhardt JA; Shi Q; Fuchs CS; Meyer J; Niedzwiecki D; Zemla T; Kumthekar P; Guthrie KA; Couture F; Kuebler P; Bendell JC; Kumar P; Lewis D; Tan B; Bertagnolli M; Grothey A; Hochster HS; Goldberg RM; Venook A; Blanke C; O'Reilly EM; Shields AF
    JAMA; 2021 Apr; 325(13):1277-1286. PubMed ID: 33821899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance.
    Jeon J; Sato K; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Wigler DS; Atienza D; Messino M; Kindler H; Venook A; Fuchs CS; Meyerhardt JA
    Clin Colorectal Cancer; 2013 Dec; 12(4):233-8. PubMed ID: 24035029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
    Van Blarigan EL; Fuchs CS; Niedzwiecki D; Zhang S; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Giovannucci EL; Ng K; Meyerhardt JA
    JAMA Oncol; 2018 Jun; 4(6):783-790. PubMed ID: 29710284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer.
    Cheng E; Shi Q; Shields AF; Nixon AB; Shergill AP; Ma C; Guthrie KA; Couture F; Kuebler P; Kumar P; Tan B; Krishnamurthi SS; Ng K; O'Reilly EM; Brown JC; Philip PA; Caan BJ; Cespedes Feliciano EM; Meyerhardt JA
    JAMA Oncol; 2023 Mar; 9(3):404-413. PubMed ID: 36701146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.
    Mlecnik B; Bifulco C; Bindea G; Marliot F; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Lafontaine L; Bruni D; Lanzi A; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Muşină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Fox BA; Pagès F; Galon J
    J Clin Oncol; 2020 Nov; 38(31):3638-3651. PubMed ID: 32897827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the duration of the capecitabine regimen following colon cancer surgery in an elderly population: a retrospective cohort study.
    Chen W; Dong H; Wang G; Chen J; Wang W
    World J Surg Oncol; 2021 Aug; 19(1):238. PubMed ID: 34380513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
    Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
    Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
    O'Connell MJ; Campbell ME; Goldberg RM; Grothey A; Seitz JF; Benedetti JK; André T; Haller DG; Sargent DJ
    J Clin Oncol; 2008 May; 26(14):2336-41. PubMed ID: 18467725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity and survival after breast cancer diagnosis.
    Holmes MD; Chen WY; Feskanich D; Kroenke CH; Colditz GA
    JAMA; 2005 May; 293(20):2479-86. PubMed ID: 15914748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
    Meyerhardt JA; Niedzwiecki D; Hollis D; Saltz LB; Hu FB; Mayer RJ; Nelson H; Whittom R; Hantel A; Thomas J; Fuchs CS
    JAMA; 2007 Aug; 298(7):754-64. PubMed ID: 17699009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
    Sinicrope FA; Shi Q; Allegra CJ; Smyrk TC; Thibodeau SN; Goldberg RM; Meyers JP; Pogue-Geile KL; Yothers G; Sargent DJ; Alberts SR
    JAMA Oncol; 2017 Apr; 3(4):472-480. PubMed ID: 28006055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
    Tie J; Cohen JD; Wang Y; Christie M; Simons K; Lee M; Wong R; Kosmider S; Ananda S; McKendrick J; Lee B; Cho JH; Faragher I; Jones IT; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Li L; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
    JAMA Oncol; 2019 Dec; 5(12):1710-1717. PubMed ID: 31621801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database.
    Salem ME; Yin J; Goldberg RM; Pederson LD; Wolmark N; Alberts SR; Taieb J; Marshall JL; Lonardi S; Yoshino T; Kerr RS; Yothers G; Grothey A; Andre T; De Gramont A; Shi Q
    Ann Oncol; 2020 Apr; 31(4):480-486. PubMed ID: 32085892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).
    Niedzwiecki D; Frankel WL; Venook AP; Ye X; Friedman PN; Goldberg RM; Mayer RJ; Colacchio TA; Mulligan JM; Davison TS; O'Brien E; Kerr P; Johnston PG; Kennedy RD; Harkin DP; Schilsky RL; Bertagnolli MM; Warren RS; Innocenti F
    J Clin Oncol; 2016 Sep; 34(25):3047-53. PubMed ID: 27432924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
    Fadelu T; Zhang S; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson AB; Atienza DM; Messino M; Kindler HL; Venook A; Ogino S; Ng K; Wu K; Willett W; Giovannucci E; Meyerhardt J; Bao Y; Fuchs CS
    J Clin Oncol; 2018 Apr; 36(11):1112-1120. PubMed ID: 29489429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.